BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 38317491)

  • 1. A Case of Long-Term Survival After Glioblastoma, IDH-Wild Type.
    Webb LM; Neth BJ; Raghunathan A; Greipp PT; Ida CM; Carabenciov ID; Ruff MW
    Neurologist; 2024 May; ():. PubMed ID: 38797928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete Response to Immune Checkpoint Inhibition in a Platinum Resistant Primary Ovarian Cancer Patient With Lynch Syndrome: A Case Report and Review of the Literature.
    Chinczewski L; Feldhaus FW; Schmitt W; Braicu I; Roser E; Sehouli J
    Anticancer Res; 2023 Apr; 43(4):1655-1662. PubMed ID: 36974818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lynch Syndrome-Associated Glioblastoma Treated With Concomitant Chemoradiotherapy and Immune Checkpoint Inhibitors: Case Report and Review of Literature.
    Nakase K; Matsuda R; Sasaki S; Nakagawa I
    Brain Tumor Res Treat; 2024 Jan; 12(1):70-74. PubMed ID: 38317491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation.
    T Danley K; Schmitz K; Ghai R; Sclamberg JS; Buckingham LE; Burgess K; Kuzel TM; Usha L
    Oncologist; 2021 Oct; 26(10):811-817. PubMed ID: 34018286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic Insights into DNA Mismatch Repair (MMR) Genes-Proteins and Microsatellite Instability: Focus on Adrenocortical Carcinoma and Beyond.
    Carsote M; Turturea IF; Turturea MR; Valea A; Nistor C; Gheorghisan-Galateanu AA
    Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of glioblastomas and immune microenvironment in a Chinese family with Lynch syndrome and concurrent porokeratosis.
    Yao ZG; Hua F; Yin ZH; Xue YJ; Hou YH; Nie YC; Zheng ZM; Zhao MQ; Guo XH; Ma C; Li XK; Wang Z; Liu GC; Zhang GH
    Front Oncol; 2023; 13():1194232. PubMed ID: 37529690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using EGFR amplification to stratify recurrent glioblastoma treated with immune checkpoint inhibitors.
    Friedman JS; Jun T; Rashidipour O; Huang KL; Ellis E; Kadaba P; Belani P; Nael K; Tsankova NM; Sebra R; Hormigo A
    Cancer Immunol Immunother; 2023 Jun; 72(6):1893-1901. PubMed ID: 36707424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Characteristics of Mismatch Repair-deficient Glioblastoma.
    Kawaguchi K; Otani R; Kikuchi M; Kushihara Y; Funata N; Yamada R; Shinoura N
    NMC Case Rep J; 2021; 8(1):565-571. PubMed ID: 35079518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors.
    Kim H; Lim KY; Park JW; Kang J; Won JK; Lee K; Shim Y; Park CK; Kim SK; Choi SH; Kim TM; Yun H; Park SH
    Lab Invest; 2022 Feb; 102(2):160-171. PubMed ID: 34848827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nivolumab with radiation therapy in a glioblastoma patient with Lynch syndrome.
    Sherman WJ; Vitaz TW
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33906875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas.
    Cho YA; Kim D; Lee B; Shim JH; Suh YL
    J Neurooncol; 2021 May; 153(1):43-53. PubMed ID: 33864561
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.